These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 10323256

  • 1. Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor.
    Nikolaus S, Huston JP, Hasenöhrl RU.
    Eur J Pharmacol; 1999 Apr 09; 370(2):93-9. PubMed ID: 10323256
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection.
    Nikolaus S, Huston JP, Hasenöhrl RU.
    Neuroreport; 1999 Aug 02; 10(11):2293-6. PubMed ID: 10439451
    [Abstract] [Full Text] [Related]

  • 4. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
    Sakurada T, Yuhki M, Inoue M, Sakurada C, Tan-No K, Ohba M, Kisara K, Sakurada S.
    Eur J Pharmacol; 1999 Mar 26; 369(3):261-6. PubMed ID: 10225361
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence.
    Hasenöhrl RU, Gerhardt P, Huston JP.
    Exp Neurol; 1992 Feb 26; 115(2):282-91. PubMed ID: 1370940
    [Abstract] [Full Text] [Related]

  • 8. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ, Naeem S, Patel IA, Walpole C, Urbán L.
    Acta Biol Hung; 1996 Feb 26; 47(1-4):129-44. PubMed ID: 9123986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH, Chan SW, Rudd JA.
    Neuropeptides; 2008 Feb 26; 42(5-6):671-9. PubMed ID: 18582934
    [Abstract] [Full Text] [Related]

  • 11. Further evidence on the anxiogenic-like effect of substance P evaluated in the elevated plus-maze in rats.
    Duarte FS, Testolin R, De Lima TC.
    Behav Brain Res; 2004 Oct 05; 154(2):501-10. PubMed ID: 15313039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S, Patacchini R, Maggi CA.
    Br J Pharmacol; 1994 Mar 05; 111(3):739-46. PubMed ID: 7517327
    [Abstract] [Full Text] [Related]

  • 19. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
    Bristow LJ, Young L.
    Eur J Pharmacol; 1994 Mar 03; 253(3):245-52. PubMed ID: 7515350
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.